VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
TECHBuyZACKSHold
R500#170 today
$17.60
+0.80% today · -1.29% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- VTRS +0.80% on the last session vs SPY +0.74%: +0.1 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 64 big drops in the past 5 years, VTRS typically gained 1.1% over the next week (median) and was higher 66% of the time; half the outcomes fell between -1.2% and +4.5%. An ordinary week: +0.3%. Among S&P 500 stocks after big drops, that ranks #58 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $20.2B
- Held by institutions
- 93.5%
- Short interest
- 3.6%
- 52-week range
- 9.69–18.43
- Analyst mean target
- —
- Next earnings
- Nov 5 BMO
- Forward P/E
- 6.6
Recent events
Earnings ▲
2Q2026 results: EPS $0.69 vs $0.60 expected beat +$0.09 (+15.0%); revenue $3.8B; next session -7.7% (-7.5 vs SPY)Earnings ▲
1Q2026 results: EPS $0.59 vs $0.50 expected beat +$0.09 (+17.5%); revenue $3.5B; next session +9.0% (+9.3 vs SPY)Earnings ▲
4Q2025 results: EPS $0.57 vs $0.53 expected beat +$0.04 (+7.4%); revenue $3.7B; next session -5.2% (-4.6 vs SPY)Earnings ▲
3Q2025 results: EPS $0.67 vs $0.62 expected beat +$0.05 (+8.5%); revenue $3.8B; next session -6.0% (-4.9 vs SPY)